These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7718890)

  • 1. TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities.
    Kaneko H; Misawa S; Horiike S; Nakai H; Kashima K
    Blood; 1995 Apr; 85(8):2189-93. PubMed ID: 7718890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
    Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
    Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
    Misawa S; Horiike S; Kaneko H; Kashima K
    Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.
    Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H
    Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.
    Kulasekararaj AG; Smith AE; Mian SA; Mohamedali AM; Krishnamurthy P; Lea NC; Gäken J; Pennaneach C; Ireland R; Czepulkowski B; Pomplun S; Marsh JC; Mufti GJ
    Br J Haematol; 2013 Mar; 160(5):660-72. PubMed ID: 23297687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the p53 gene in myelodysplastic syndromes.
    Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
    Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
    Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
    Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation in the myelodysplastic syndromes.
    Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE
    Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations in myelodysplastic syndrome.
    Misawa S; Horiike S
    Leuk Lymphoma; 1996 Nov; 23(5-6):417-22. PubMed ID: 9031070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes.
    Mitani K; Hangaishi A; Imamura N; Miyagawa K; Ogawa S; Kanda Y; Yazaki Y; Hirai H
    Leukemia; 1997 Jun; 11(6):863-5. PubMed ID: 9177441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.
    Mori N; Hidai H; Yokota J; Okada M; Motoji T; Oshimi K; Mizoguchi H
    Leuk Res; 1995 Nov; 19(11):869-75. PubMed ID: 8551805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome.
    Talwalkar SS; Yin CC; Naeem RC; Hicks MJ; Strong LC; Abruzzo LV
    Arch Pathol Lab Med; 2010 Jul; 134(7):1010-5. PubMed ID: 20586629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.